secondary-account-menu

Profile

Orders

Wish List

Fast Order Entry

My Account

mega-menu

Browse by Institution Type

Browse by Product Type

Products

Support

footer-menu

Academic Institutions

K-12

Public Libraries

Government and Special Libraries

Statewide Programs

Institutions

Databases

Primary Sources

Digital Humanities Tools

eLearning

Schools/K-12 Curriculum

Books

Large Print Books by Thorndike Press

Find Your Rep

Product Support

Technical Support

Customer Support

Admin Tools

Accessibility Policy

About Us

Blogs

Press Center

Events

News

Careers

Partnerships

Contact Us

Our Company

single-column

footer-legal-menu-component

products

Marketing materials, training documents, discovery services

cengage:card

FIND YOUR SALES REPRESENTATIVE

cengage:column

Get marketing materials, training documents, discovery services.

PRODUCT SUPPORT

CUSTOMER SUPPORT

Report technical issues, errors, check system status

TECHNICAL SUPPORT

Manage product preferences, generate usage reports, simplify administrative tasks.

ADMIN TOOLS

support

footer

footer-social-menu-component

cengage:galethorndikeseo

zone3

zone1

container

header

zone2

footer-menu-component

secondary-storefront-menu

International

North America

China

Japan

Latin America

Brazil

Region

Set your region:

Would you like to go to the Gale {{RECOMMENDED_COUNTRY}} site instead?

It looks like you're visiting from {{DETECTED_COUNTRY}}.

main

header-component

config

footer-social-menu

Sign Up for Emails

CONNECT WITH GALE

Stay up-to-date with the latest Gale news, exclusive offers, and more.

facebook

linkedin

instagram

youtube

SOCIAL ICONS

gale-footer

footer-legal-menu

Terms of use

Privacy

FIND YOUR REP

support-order-2

Account Information

bundle-connector

%1 products have been added to your cart but %2 have been backordered and will be fulfilled when stock is available

Product on backorder

Current quantity limit is [maxProductQuantity], please, navigate to the cart page and change quantity of product

You will be able to resubmit promo in ${countdown} seconds. test

Please note that the taxes displayed on our website are estimated and subject to adjustment. The actual tax charges will be determined and settled during the final invoicing of your order

product-detail-component

secondary-primary-menu

Request a Trial

You may already have access to Gale content through your institution.

STUDENTS AND RESEARCHERS

support-order-1

Developing Therapeutics for Alzheimer's Disease

DEVELOPING THERAPEUTICS FOR ALZHEIMERS DISEASE

Diseases & Conditions

Health, Medicine & Nursing

Gt Product Group

Binding Format

Marketing Imprint Name

B2B GT

CL Carton Count

Imprint Name

B2B & B2C

<P>This compilation provides a thorough overview of the latest research and challenges associated with developing therapeutics for Alzheimer’s disease.</P>

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges

College Freshman

College Sophomore

College Junior

College Senior

Duration

Duration Unit Of Measure

Transaction Type

Front Cover.
Half Title Page.
Title Page.
Copyright Page.
Dedication.
Contents.
List of Contributors.
Foreword.
Preface.
1: The Complex Pathways to Mechanism-Based Therapeutics in Alzheimer&#x0027;s Disease.
2: The Genetic Basis of Alzheimer&#x0027;s Disease.
3: &#x03B3;-Secretase Inhibition.
4: &#x03B3;-Secretase Inhibitors: From Chemical Probes to Drug Development.
5: Therapeutic Targeting of A&#x03B2;42.
6: Modulators of Amyloid &#x03B2;-Protein (A&#x03B2;) Self-Assembly.
7: Anti-Amyloid-&#x03B2; Immunotherapy for Alzheimer&#x0027;s Disease.
8: Targeting A&#x03B2; Receptors to Modify Alzheimer&#x0027;s Disease Progression.
9: Blood&#x2013;Brain Barrier Transport of Alzheimer&#x0027;s Amyloid &#x03B2;-Peptide.
10: Alzheimer&#x0027;s Disease Therapeutics Targeting Apolipoprotein E.
11: Microtubule Stabilization.
12: Tau Phosphorylation as a Therapeutic Target in Alzheimer&#x0027;s Disease.
13: Stimulation of Tau Degradation.
14: Passive Immunotherapy for Tau Pathology.
15: Inhibition of Tau Aggregation as a Basis for Treatment and Prevention of Alzheimer&#x0027;s Disease.
16: Neuroprotective Strategies for Alzheimer&#x0027;s Disease Prevention and Therapy.
17: Symptomatic Cognitive Enhancing Agents.
18: Tackling Alzheimer&#x0027;s Disease by Targeting Oxidative Stress and Mitochondria.
19: Clinical Issues in Alzheimer Drug Development.
20: Molecular Imaging in Alzheimer Clinical Trials.
21: Fluid Biomarkers and Diagnostics.
22: Nonpharmacologic Activity Interventions to Prevent Alzheimer&#x0027;s Disease.
23: Prospects and Challenges for Alzheimer Therapeutics.
Index.

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges.css-1p8rvzy{position:absolute;padding-left:8px;}

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges